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Long-term Effectiveness and Treatment Timing
for Bionator Therapy
Kurt Faltin Jr, DDS, PhD;a Rolf M. Faltin, DDS, MSc, PhD;b Tiziano Baccetti, DDS, PhD;c
Lorenzo Franchi, DDS, PhD;c Bruno Ghiozzi, DDS;d James A. McNamara Jr, DDS, PhDe
Abstract: The aim of the present investigation was to provide information about the long-term effects
and optimal timing for class-II treatment with the Bionator appliance. Lateral cephalograms of 23 class-II
patients treated with the Bionator were analyzed at three time periods: T1, start of treatment; T2, end of
Bionator therapy; and T3, long-term observation (after completion of growth). T3 includes a phase with
fixed appliances. The treated sample was divided into two groups according to their skeletal maturity as
evaluated by the cervical vertebral maturation (CVM) method. The early-treated group (13 subjects) initiated
treatment before the peak in mandibular growth, which occurred after completion of Bionator therapy. The
late-treated group (10 subjects) received Bionator treatment during the peak. The T1–T2, T2–T3, and
T1–T3 changes in the treated groups were compared with changes in control groups of untreated class-II
subjects by nonparametric statistics (P , .05). The findings of the present study on Bionator therapy followed
by fixed appliances indicate that this treatment protocol is more effective and stable when it is performed
during the pubertal growth spurt. Optimal timing to start treatment with the Bionator is when a concavity
appears at the lower borders of the second and the third cervical vertebrae (CVMS II). In the long term, the
amount of significant supplementary elongation of the mandible in subjects treated during the pubertal peak
is 5.1 mm more than in the controls, and it is associated with a backward direction of condylar growth.
Significant increments in mandibular ramus height also were recorded. (Angle Orthod 2003;73:221–230.)
Key Words: Class-II malocclusion; Functional jaw orthopedics; Cephalometrics; Cervical vertebral
maturation
INTRODUCTION
The Balters’ Bionator1,2 is one of the most commonly
used appliances for functional treatment of class-II, division
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1 malocclusions associated with mandibular retrusion. The
popularity of this appliance is due in part to a number of
favorable characteristics that include the relative ease in the
construction and clinical handling of the appliance and the
high level of comfort for the patient, who usually shows
positive acceptance and compliance. The generic term
Bionator, as a matter of fact, describes a ‘‘family’’ of tooth-
borne appliances that produce a forward positioning of the
mandible in association with variable effects in the vertical
plane, ie, open, close, or maintain the bite.3
After its introduction in 1964, the Bionator has been the
object of several investigations aimed to identify both the
dentoalveolar and skeletal effects of this appliance. Most
studies dealt with short-term outcomes of Bionator therapy
by using various types of control groups (untreated class-I
or class-II subjects).4–8
Dentoalveolar changes consist of maxillary incisor re-
traction and uprighting, associated with proclination of the
lower incisors (when capping of these teeth is not used).
An increase in mandibular molar eruption caused by ad-
justments in the eruption facets of the appliance has been
documented as well. Although no skeletal modification has
been found for the maxilla, a favorable increase in total
222 FALTIN, FALTIN, BACCETTI, FRANCHI, GHIOZZI, MCNAMARA
Angle Orthodontist, Vol 73, No 3, 2003
FIGURE 1. The new CVM method.
mandibular length has been described consistently in pa-
tients treated with the Bionator. The skeletal changes are
associated with significant effects on the soft tissues, mainly
consisting of changes in the vertical dimensions of the face
and position of the lips.9,10
Recently, the issue of optimal treatment timing for func-
tional jaw orthopedics has gained the attention of both re-
searchers and clinicians. Cephalometric studies have shown
that the therapeutic effectiveness of the most functional ap-
pliances11–17 is greatest when these appliances are used dur-
ing the ascending portion of the individual pubertal growth
spurt. Typically, patients treated during the peak period
demonstrate significant skeletal effects induced by the ap-
pliance, whereas patients treated in the prepeak period have
the significant effects confined to the dentoalveolar level.
The Bionator is no exception to these findings, as docu-
mented in the studies by Janson.4,5 In her short-term inves-
tigation, Janson described an insignificant slight increase in
mandibular size when the Bionator was used during pre-
pubertal developmental stages, whereas the mandibular
changes became significant over untreated controls when
the peak was included in the treatment period.
To our knowledge, the only long-term study on the cra-
niofacial changes induced by the Bionator is by Rudzki-
Janson and Noachtar,18 who evaluated a group of patients
treated with the Bionator five years after the completion of
retention. These patients showed an increase in the size of
the mandible and a decrease in both the distal skeletal jaw
relationship and the gonial angle. However, the lack of a
control group of untreated subjects and the use of treatment
outcome as criteria for case selection are limiting factors
for an adequate appraisal of the effectiveness of Bionator
therapy in the long term. Furthermore, no assessment of
ideal treatment timing for this type of treatment was at-
tempted in the study.
The aim of the present investigation is to provide infor-
mation about the long-term effects of class-II malocclusion
treatment with the Bionator and, concurrently, to analyze
differences in the dentoskeletal response of patients treated
before or during the peak in mandibular growth. The
strengths of the study are the use of a group of untreated
class-II subjects and the appraisal of stages in individual
skeletal maturity by the cervical vertebral maturation
(CVM) method.
SUBJECTS AND METHODS
The cephalometric records of 30 class-II malocclusion
patients consecutively treated with the Bionator were col-
lected from a single orthodontic practice where this type of
therapy was used. The treatment protocol consisted of
class-II correction by a Bionator constructed without cov-
erage of the lower incisors, followed by approximately one
year of fixed appliance therapy to refine occlusion. After
the comprehensive phase, each patient was given a fixed
lower incisor retainer.
Seven patients were eliminated from the study because
of the pretreatment absence of a full class-II molar rela-
tionship or poor film quality. The remaining 23 sets of
cephalograms were analyzed. Final successful completion
of therapy was not a criterion for case selection. Lateral
cephalograms were obtained at three time periods: T1, at
the start of treatment; T2, at the end of Bionator therapy;
and T3, at long-term observation after completion of
growth. Therefore, the effects of active treatment with the
Bionator were assessed during the T1–T2 interval, whereas
the analysis of T2–T3 interval provided information about
the posttreatment changes that included a phase of treat-
ment with fixed appliances to refine the occlusion. The T1–
T3 interval was used to describe the overall treatment and
posttreatment dentoskeletal modifications.
The treated sample was divided into two groups accord-
ing to skeletal maturity at the start of treatment as evaluated
by a recently implemented version of the CVM method.19,20
This version of the CVM method includes five maturational
stages (CVMS I through CVMS V, instead of Cvs 1 through
Cvs 6 in the former CVM method;21 Figure 1). The peak
in mandibular growth occurs between CVMS II and CVMS
III; the peak has not been reached without the attainment
of CVMS II. CVMS V is recorded at least two years after
the peak. The advantages of the new version of the CVM
method are that mandibular skeletal maturity can be ap-
praised on a single cephalogram and that it involves the
analysis of only the second, third, and fourth cervical ver-
tebrae, which usually are visible even when a protective
radiation collar is worn.
The early-treated group (ETG; Table 1) consisted of 13
subjects (seven females and six males) presenting with
CVMS I in cervical vertebrae maturation at T1. The stages
in cervical vertebrae maturation at T2 were either CVMS I
or CVMS II. Therefore, the peak in growth velocity was
not included in the period of treatment with the Bionator
for any of the subjects in the early group. The stages in
cervical vertebrae maturation at T3 were either CVMS IV
or CVMS V. The late-treated group (LTG; Table 1) included
10 subjects (six females and four males) presenting with
CVMS II in cervical vertebrae maturation at T1. The stages
in cervical vertebrae maturation at T2 were either CVMS
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TABLE 1. Descriptive Statistics for Age and Observation Periods
Mean Age
T1 T2 T3
Mean Observation Period
T1–T2 T2–T3 T1–T3
Early-treated group
(n 5 13) 9 y 8 mo 6 1 y 3 mo 11 y 6 mo 6 1 y 3 mo 17 y 5 mo 6 2 y 1 y 10 mo 6 7 mo 5 y 10 mo 6 2 y 2 mo 7 y 8 mo 6 2 y 5 mo
Early control group
(n 5 11) 9 y 5 mo 6 1 y 3 mo 11 y 6 mo 6 1 y 4 mo 16 y 4 mo 6 1 y 9 mo 2 y 1 mo 6 7 mo 4 y 10 mo 6 1 y 10 mo 6 y 10 mo 6 1 y 6 mo
Late-treated group
(n 5 10) 10 y 9 mo 6 1 y 8 mo 13 y 2 mo 6 2 y 3 mo 19 y 2 mo 6 2 y 2 mo 2 y 4 mo 6 1 y 6 mo 6 y 0 mo 6 10 mo 8 y 4 mo 6 1 y 8 mo
Late control group
(n 5 10) 11 y 2 mo 6 1 y 6 mo 12 y 11 mo 6 1 y 9 mo 17 y 2 mo 6 1 y 1 mo 1 y 9 mo 6 8 mo 4 y 3 mo 6 2 y 3 mo 6 y 0 mo 6 1 y 10 mo
FIGURE 2. Cephalometric analysis.
III or CVMS IV. Therefore, the peak in growth velocity
was included in the period of treatment with the Bionator
for all the subjects in the late group. The stage in cervical
vertebrae maturation at T3 was CVMS V.
The treated sample was compared with a sample of 21
subjects with untreated class-II malocclusions (control sam-
ple) selected from the University of Michigan Elementary
and Secondary School Growth Study.22 The control sample
also was divided into two groups according to the stage in
CVM.
The early control group (ECG; Table 1) included 11 sub-
jects (five females and six males), whereas the late control
group (LCG; Table 1) consisted of 10 subjects (five females
and five males). The control groups matched the corre-
sponding treated groups to the stage in CVM at each ob-
servation period (T1, T2, and T3). The relatively shorter
T2–T3 interval of observation in the LCG when compared
with LTG did not affect the interpretation of the data be-
cause all the subjects in both LCG and LTG had completed
the active phase of skeletal growth at T3 (CVMS V).
Cephalometric analysis
Lateral cephalograms of both treated groups and both
control groups at T1, T2, and T3 were standardized to the
magnification factor and analyzed by a digitizing tablet
(Numonics, Lansdale, Pennsylvania, PA) and digitizing
software (Viewbox, ver. 2.6).23
A cephalometric analysis derived from both Johnston’s24
and Pancherz’s25 original analyses and comprising a modi-
fied reference system for the superimposition procedure
was applied. The definitions for the landmarks used in the
analysis have been provided previously.26
The occlusal line (OL) and the occlusal line perpendi-
culare (OLp) from the cephalogram at T1 were used as a
reference grid. The grid was transferred from the initial
tracing to subsequent tracings at T2 and T3 by superim-
posing the tracings on the T-FMN line, with T point as the
registration point. All linear measurements were performed
parallel to OL and perpendicular to OLp. The following
variables were measured (Figure 2).
• is/OLp minus ii/OLp—overjet;
• ms/OLp minus mi/OLp—molar relation (a positive value
indicates a distal relation; a negative value indicates a
mesial relation);
• A point/OLp—sagittal position of the maxillary base;
• pg/OLp—sagittal position of the mandibular base;
• co/OLp—sagittal position of the condylar head;
• pg/OLp 1 co/OLp—composite mandibular length;
• is/OLp minus A point/OLp—sagittal position of the max-
illary central incisor within the maxilla;
• ii/OLp minus pg/OLp—sagittal position of the mandib-
ular central incisor within the mandible;
• ms/OLp minus A point/OLp— sagittal position of the
maxillary permanent first molar within the maxilla;
• mi/OLp minus pg/OLp—sagittal position of the mandib-
ular permanent first molar within the mandible.
Additional measurements for cranial base angulation,
mandibular dimensions, and skeletal vertical relationships
were obtained on all cephalograms at T1, T2, and T3, in-
dependently from the superimposition reference system
(Figure 3).
• linear measurements—co-pg, co-go, go-pg;
• angular measurements—FMN-T-ba, FMN-T-ar, cl-ml, ar-
goi-me, nl/T-FMN line, ml/T-FMN line, nl-ml.
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FIGURE 3. Additional cephalometric measures.
The method error and the coefficient of reliability for the
cephalometric measurements have been described previ-
ously.26
Statistical analysis
The starting forms of ETG and LTG were compared with
those in ECG and LCG, respectively. Craniofacial modifi-
cations in the treated groups were compared with the
growth modifications occurring in the corresponding con-
trol groups. In particular, T1–T2 changes were analyzed to
describe the effects of active therapy with the Bionator. T2–
T3 changes indicated posttreatment modifications including
a phase with fixed appliances. T1–T3 changes provided in-
formation about the long-term overall effects of both treat-
ment and posttreatment intervals. All statistical compari-
sons were performed by a nonparametric test due to the
limited number of subjects in each group (Mann-Whitney
U-test, P , .05). The tests were carried out by using a
commercial statistical package (SPSS for Windows, release
10.0.0, SPSS Inc).
RESULTS
Comparison of starting forms
No statistically significant difference was found in the
craniofacial configurations at T1 in ETG and LTG when
compared with ECG and LCG, respectively. All groups
showed an average overjet of more than six mm and a full
cusp class-II molar relationship.
Treatment effects in the ETG (Table 2)
Treatment with the Bionator appliance before the puber-
tal peak produced a significant overjet correction of 3.2 mm
and a significant sagittal correction in molar relation of 2.6
mm when compared with growth changes in the ECG. The
main contribution to occlusal correction was due to a small-
er, though insignificant, increase in maxillary protrusion in
ETG when compared with ECG. No other significant mod-
ifications were detected in the ETG during active therapy.
Posttreatment changes in the ETG (Table 3)
No significant modification was found during the post-
treatment period in ETG when compared with ECG. Both
overjet and molar relation remained virtually unchanged af-
ter Bionator therapy.
Overall treatment and posttreatment changes in
the ETG (Table 4)
At the completion of the overall observation period, no
significant difference in the dentoskeletal configuration of
the patients treated before the pubertal growth spurt was
recorded. Treatment produced an overjet correction of 1.6
mm and a correction in molar relation of 2.2 mm when
compared with changes in the ECG.
Treatment effects in the LTG (Table 5)
Treatment with the Bionator appliance when the pubertal
peak was included in the active treatment period induced a
significant overjet correction of 4.4 mm and a correction in
molar relation of 1.8 mm when compared with changes in
the LCG. A significant mesial advancement of the mandib-
ular dentition at both the molar and incisor regions occurred
in LTG. At the skeletal level, supplementary increases in
total mandibular length and in ramus height (of 4.3 mm
both), along with a significant opening of the gonial angle
and of the angle between the condylar line and the man-
dibular line, were found in LTG when compared with LCG.
Posttreatment changes in the LTG (Table 6)
As for ETG vs ECG, no significant modification was
found during the posttreatment period in LTG when com-
pared with LCG either. Both overjet and molar relation re-
mained almost unchanged after Bionator therapy.
Overall treatment and posttreatment changes in
the LTG (Table 7)
In the long term, the patients treated during the pubertal
growth spurt showed a significant overjet correction of 4.2
mm and a correction in molar relation of 2.1 mm when
compared with changes in the LCG. Significantly greater
increments in total mandibular length (15.1 mm) and in
ramus height (14.8 mm) were assessed in LTG when com-
pared with LCG. These changes were associated with a
significantly greater growth increment of the mandibular
condyle in a backward direction in LTG, and with a sig-
nificant opening of the gonial angle and of the angle be-
225LONG-TERM EFFECTS OF BIONATOR
Angle Orthodontist, Vol 73, No 3, 2003
TABLE 2. Changes T2–T1 in the Early Groupsa
Variable
Early-Treated Group
(ETG) (n 5 13)
Mean SD
Early Control Group
(ECG) (n 5 11)
Mean SD
Mann-
Whitney
U-test
Group
Difference
ETG/ECG
(Treatment
Effect)
Cephalometric analysis (mm)
Overjet (is/OLp minus ii/OLp)
Molar relation (ms/OLp minus mi/OLp)
Maxillary base (A point/OLp)
Mandibular base (pg/OLp)
Condylar head (co/OLp)
Composite mandibular length (pg/OLp 1 co/OLp)
Maxillary incisor (is/OLp minus A point/OLp)
Mandibular incisor (ii/OLp minus pg/OLp)
Maxillary molar (ms/OLp minus ss/OLp)
Mandibular molar (mi/OLp minus pg/OLp)
23.2
22.9
11.7
14.5
10.4
14.1
20.4
20.0
20.1
0.0
2.1
2.0
2.1
3.9
1.9
3.9
2.1
1.9
2.7
2.0
10.0
20.3
13.6
13.7
20.7
14.4
20.6
20.7
20.4
20.2
2.0
1.5
1.9
2.2
1.2
2.7
1.8
0.8
1.5
0.9
S
S
NS
NS
NS
NS
NS
NS
NS
NS
23.2
22.6
21.9
10.8
11.1
20.3
10.2
10.7
10.3
10.2
FMN-T point-ba (8)
FMN-T point-ar (8)
co-pg (mm)
co-go (mm)
go-pg (mm)
cl-ml (8)
ar-goi-me (8)
nl/FMN-T line (8)
ml/FMN-T line (8)
nl-ml (8)
20.6
21.0
15.0
12.5
13.1
10.2
10.8
10.2
20.3
20.6
2.8
2.1
2.6
2.1
1.7
2.2
1.9
2.4
2.3
2.2
20.6
20.7
14.2
12.6
12.6
20.4
21.0
20.3
21.6
21.3
1.4
1.8
2.8
2.7
1.7
1.4
1.4
1.9
1.9
1.5
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
10.0
20.3
10.8
20.1
10.5
10.6
11.8
10.5
11.3
10.7
a S 5 significant comparison (P , .05); NS 5 not significant comparison.
TABLE 3. Changes T3–T2 in the Early Groupsa
Variable
Early-Treated Group
(ETG) (n 5 13)
Mean SD
Early Control Group
(ECG) (n 5 11)
Mean SD
Mann-
Whitney
U-test
Group
Difference
ETG/ECG
(Posttreatment
Changes)
Cephalometric analysis (mm)
Overjet (is/OLp minus ii/OLp)
Molar relation (ms/OLp minus mi/OLp)
Maxillary base (A point/OLp)
Mandibular base (pg/OLp)
Condylar head (co/OLp)
Composite mandibular length (pg/OLp 1 co/OLp)
Maxillary incisor (is/OLp minus A point/OLp)
Mandibular incisor (ii/OLp minus pg/OLp)
Maxillary molar (ms/OLp minus ss/OLp)
Mandibular molar (mi/OLp minus pg/OLp)
10.0
20.7
12.6
16.8
21.3
18.1
11.9
22.3
12.5
21.0
1.1
2.0
2.3
3.7
1.7
3.8
2.1
1.7
3.8
2.5
21.6
21.1
11.8
15.4
21.5
16.8
10.3
21.5
12.6
10.2
2.6
1.7
2.8
4.2
1.9
3.6
2.7
2.1
2.3
2.6
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
11.6
10.4
10.8
11.4
10.2
11.3
11.6
20.8
20.1
21.2
FMN-T point-ba (8)
FMN-T point-ar (8)
co-pg (mm)
co-go (mm)
go-pg (mm)
cl-ml (8)
ar-goi-me (8)
nl/FMN-T line (8)
ml/FMN-T line (8)
nl-ml (8)
20.3
10.4
110.5
16.7
16.7
22.7
24.2
20.2
21.9
22.1
1.9
2.5
4.1
2.4
3.3
2.7
3.3
2.1
2.5
3.0
10.4
11.1
19.3
16.1
16.0
22.2
22.4
1.1
20.8
21.9
2.2
3.5
3.4
2.0
3.3
2.4
2.5
2.2
2.0
1.2
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
20.7
20.7
11.2
10.6
10.7
20.5
21.8
21.3
21.1
20.2
a S 5 significant comparison (P , .05); NS 5 not significant comparison.
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TABLE 4. Changes T3–T1 in the Early Groupsa
Variable
Early-Treated Group
(ETG) (n 5 13)
Mean SD
Early Control Group
(ECG) (n 5 11)
Mean SD
Mann-
Whitney
U-test
Group
Difference
ETG/ECG
(Long-Term
Changes)
Cephalometric analysis (mm)
Overjet (is/OLp minus ii/OLp)
Molar relation (ms/OLp minus mi/OLp)
Maxillary base (A point/OLp)
Mandibular base (pg/OLp)
Condylar head (co/OLp)
Composite mandibular length (pg/OLp 1 co/OLp)
Maxillary incisor (is/OLp minus A point/OLp)
Mandibular incisor (ii/OLp minus pg/OLp)
Maxillary molar (ms/OLp minus ss/OLp)
Mandibular molar (mi/OLp minus pg/OLp)
23.2
23.6
14.3
111.3
20.9
112.3
11.5
22.3
12.5
20.9
2.7
1.5
2.5
5.1
1.7
5.4
1.3
1.8
4.4
3.3
21.6
21.4
15.4
19.1
22.1
111.2
20.2
22.1
12.2
0.0
2.4
1.5
2.7
4.3
1.9
2.9
2.6
2.0
2.4
3.0
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
21.6
22.2
21.1
12.2
11.2
11.0
11.7
20.1
10.3
20.9
FMN-T point-ba (8)
FMN-T point-ar (8)
co-pg (mm)
co-go (mm)
go-pg (mm)
cl-ml (8)
ar-goi-me (8)
nl/FMN-T line (8)
ml/FMN-T line (8)
nl-ml (8)
20.9
20.6
115.4
19.2
19.7
22.5
23.4
10.4
22.2
22.7
2.4
2.8
4.9
3.0
3.8
2.5
3.5
2.2
3.1
3.4
20.2
10.4
113.5
18.7
18.6
22.6
23.3
10.7
22.4
23.1
1.3
2.4
3.2
2.5
2.9
2.0
2.2
1.8
2.9
2.1
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
20.7
21.0
11.9
10.5
11.1
10.1
20.1
20.3
10.2
10.4
a S 5 significant comparison (P , .05); NS 5 not significant comparison.
TABLE 5. Changes T2–T1 in the Late Groupsa
Variable
Late-Treated Group
(LTG) (n 5 10)
Mean SD
Late Control Group
(LCG) (n 5 10)
Mean SD
Mann-
Whitney
U-test
Group
Difference
LTG/LCG
(Treatment
Effect)
Cephalometric analysis (mm)
Overjet (is/OLp minus ii/OLp)
Molar relation (ms/OLp minus mi/OLp)
Maxillary base (A point/OLp)
Mandibular base (pg/OLp)
Condylar head (co/OLp)
Composite mandibular length (pg/OLp 1 co/OLp)
Maxillary incisor (is/OLp minus A point/OLp)
Mandibular incisor (ii/OLp minus pg/OLp)
Maxillary molar (ms/OLp minus ss/OLp)
Mandibular molar (mi/OLp minus pg/OLp)
24.1
22.2
11.2
12.1
21.7
13.8
21.9
11.3
10.1
11.4
2.1
1.7
2.0
5.8
1.7
5.3
3.1
2.1
2.1
3.7
10.3
20.4
11.2
12.0
20.5
12.5
20.3
21.3
10.3
0.0
1.1
0.9
1.6
1.4
1.5
2.0
2.3
1.8
1.6
0.7
S
S
NS
NS
NS
NS
NS
S
NS
S
24.4
21.8
0.0
10.1
21.2
11.3
21.6
12.6
20.2
11.4
FMN-T point-ba (8)
FMN-T point-ar (8)
co-pg (mm)
co-go (mm)
go-pg (mm)
cl-ml (8)
ar-goi-me (8)
nl/FMN-T line (8)
ml/FMN-T line (8)
nl-ml (8)
11.2
11.5
17.2
15.1
13.1
11.2
10.5
11.6
11.3
20.3
1.6
2.2
4.9
3.3
3.5
2.0
1.8
2.4
2.1
2.6
11.5
11.2
12.9
10.8
13.2
21.2
22.7
0.0
20.2
20.2
4.6
3.3
3.7
3.1
3.6
4.5
2.9
1.7
1.8
1.6
NS
NS
S
S
NS
S
S
NS
NS
NS
20.3
10.3
14.3
14.3
20.1
12.4
13.2
11.6
11.5
20.1
a S 5 significant comparison (P , .05); NS 5 not significant comparison.
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TABLE 6. Changes T3–T2 in the Late Groupsa
Variable
Late-Treated Group
(LTG) (N 5 10)
Mean SD
Late Control Group
(LCG) (N 5 10)
Mean SD
Mann-
Whitney
U-test
Group
Difference
LTG/LCG
(Posttreatment
Changes)
Cephalometric analysis (mm)
Overjet (is/OLp minus ii/OLp)
Molar relation (ms/OLp minus mi/OLp)
Maxillary base (A point/OLp)
Mandibular base (pg/OLp)
Condylar head (co/OLp)
Composite mandibular length (pg/OLp 1 co/OLp)
Maxillary incisor (is/OLp minus A point/OLp)
Mandibular incisor (ii/OLp minus pg/OLp)
Maxillary molar (ms/OLp minus ss/OLp)
Mandibular molar (mi/OLp minus pg/OLp)
20.5
20.6
10.4
14.8
21.8
16.6
11.3
22.7
12.8
21.0
1.4
1.6
2.6
4.1
1.6
3.0
1.5
2.1
1.5
1.4
20.8
20.5
12.5
15.0
20.5
15.5
0.0
21.7
12.1
10.1
1.4
1.0
2.4
4.0
2.0
4.4
1.8
1.9
2.2
2.1
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
10.3
20.1
22.1
20.2
21.3
11.1
11.3
21.0
10.7
21.1
FMN-T point-ba (8)
FMN-T point-ar (8)
co-pg (mm)
co-go (mm)
go-pg (mm)
cl-ml (8)
ar-goi-me (8)
nl/FMN-T line (8)
ml/FMN-T line (8)
nl-ml (8)
10.6
11.2
17.1
14.9
14.4
21.4
21.8
10.5
21.6
22.1
2.7
2.2
2.7
2.4
2.5
2.3
2.3
1.5
1.9
2.1
21.1
20.5
16.5
14.4
14.1
22.5
21.8
20.5
21.7
21.2
2.0
2.1
5.0
3.7
4.7
4.1
4.5
2.8
2.2
2.6
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
11.7
11.7
10.6
10.5
10.3
11.1
0.0
11.0
10.1
20.9
a S 5 significant comparison (P , .05); NS 5 not significant comparison.
TABLE 7. Changes T3–T1 in the Late Groupsa
Variable
Late-Treated Group
(LTG) (n 5 10)
Mean SD
Late Control Group
(LCG) (n 5 10)
Mean SD
Mann-
Whitney
U-test
Group
Difference
LTG/LCG
(Long-Term
Changes)
Cephalometric analysis (mm)
Overjet (is/OLp minus ii/OLp)
Molar relation (ms/OLp minus mi/OLp)
Maxillary base (A point/OLp)
Mandibular base (pg/OLp)
Condylar head (co/OLp)
Composite mandibular length (pg/OLp 1 co/OLp)
Maxillary incisor (is/OLp minus A point/OLp)
Mandibular incisor (ii/OLp minus pg/OLp)
Maxillary molar (ms/OLp minus ss/OLp)
Mandibular molar (mi/OLp minus pg/OLp)
24.6
22.9
11.6
17.0
23.4
110.4
20.6
21.4
12.9
10.4
2.5
1.9
3.4
7.2
2.5
6.1
3.2
3.0
2.8
3.8
20.4
20.8
13.8
17.0
21.0
18.0
20.2
23.0
12.5
10.1
1.2
1.2
2.9
4.6
2.2
5.2
3.2
2.6
3.2
2.5
S
S
NS
NS
S
NS
NS
NS
NS
NS
24.2
22.1
22.2
0.0
22.4
12.4
20.4
11.6
10.4
10.3
FMN-T point-ba (8)
FMN-T point-ar (8)
co-pg (mm)
co-go (mm)
go-pg (mm)
cl-ml (8)
ar-goi-me (8)
nl/FMN-T line (8)
ml/FMN-T line (8)
nl-ml (8)
11.8
12.8
114.4
110.0
17.4
20.2
21.3
12.1
20.3
22.4
3.7
4.2
5.4
3.4
4.3
1.9
2.4
3.0
2.9
3.2
10.5
10.6
19.3
15.2
17.3
23.7
24.5
20.5
21.9
21.4
3.9
3.2
5.3
3.7
3.2
2.6
3.0
3.2
2.8
3.0
NS
NS
S
S
NS
S
S
NS
NS
NS
11.3
12.2
15.1
14.8
10.1
13.5
13.2
12.6
11.6
21.0
a S 5 significant comparison (P , .05); NS 5 not significant comparison.
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tween the condylar line and the mandibular line in the
group that received treatment during the pubertal growth
spurt.
DISCUSSION
Even though the Bionator has been part of routine func-
tional appliance therapy for nearly four decades, surpris-
ingly few methodologically sound clinical studies of this
treatment approach, at least by today’s standards, have ap-
peared in the orthodontic literature. Although several ceph-
alometric investigations on the short-term treatment effects
of the Bionator appliance in growing subjects with class-II
malocclusion have been published,4–8 no previous research
has dealt with the issue of long-term response to this type
of therapy. The only contribution that analyzed treatment
outcomes of the Bionator in the long term is by Rudzki-
Janson and Noachtar18 that does not include an untreated
control sample for the appraisal of treatment effectiveness.
The need for adequate information regarding the long-
term dentoskeletal modifications that can be produced by
the Bionator appears compelling because the Bionator is
one of the most commonly used appliances for functional
jaw orthopedics. Furthermore, the efficiency of a given
treatment protocol in dentofacial orthopedics has to be eval-
uated not only on the basis of treatment effectiveness but
also for the issue of optimal treatment timing to achieve
significant changes in the craniofacial structures. With these
aims in mind, the present study analyzed the long-term
skeletal and dentoalveolar changes after Bionator therapy
in two different groups of class-II individuals at different
stages of skeletal maturation.
The appraisal of skeletal maturity in both treated and
untreated class-II samples was performed by the evaluation
of growth stages in the cervical vertebrae, according to a
recently modified version of the original CVM method. The
original method has been used in previous papers16,17 to
identify ideal treatment timing for other functional appli-
ances such as the twin-block and the FR-2. In the present
investigation, the newly developed CVM method19,20 (based
on the evaluation of the morphological features of the sec-
ond, third, and fourth cervical vertebrae only) was adopted
to discriminate between a group of subjects treated before
the onset of the pubertal spurt in mandibular growth (ETG)
and a group of subjects who started treatment during the
spurt (LTG). Both groups were reevaluated after the com-
pletion of growth (about six years after active treatment
with the Bionator had been terminated). The posttreatment
period in both early and late groups included a short phase
of therapy with fixed appliances to refine and detail the
occlusion.
The findings of the present study indicate clearly that
significant long-term changes in the occlusal relationships
and mandibular growth increments can be achieved by
Bionator therapy only when functional treatment includes
the pubertal growth spurt. According to the new CVM
method, these data indicate that functional jaw orthopedics
with the Bionator should start not earlier than CVMS II
(when a concavity is evident at the lower borders of both
the second and third cervical vertebrae). In the long term,
the late-treated subjects, who started Bionator treatment at
the growth spurt, showed a significant improvement in the
overjet (24.2 mm) and a favorable change in the molar
relation (22.1 mm). The amount of supplementary elon-
gation of the mandible in the LTG when compared with
corresponding controls (5.1 mm) was two and a half times
that of the ETG (1.9 mm), and it was produced almost
entirely by Bionator therapy. Posttreatment changes were
not significant. The greater increase in total mandibular
length (co-pg) was associated with significant supplemen-
tary increases in the height of the mandibular ramus (co-
go, 4.8 mm) in the group treated at the peak when com-
pared with the corresponding control group, whereas only
a 0.5-mm change for this measurement was recorded in the
ETG. These results have significance not only at the statis-
tical level but also are relevant clinically.
The significant supplementary growth of the mandible in
the LTG was concurrent with favorable changes in both the
anteroposterior position (co-OLp) and the growth direction
(cl-ml) of the mandibular condyle. This growth modifica-
tion has been described in the past as ‘‘posterior mandibular
morphogenetic rotation,’’14 a biological mechanism leading
to greater increments in total mandibular length and, thus,
efficiently improving the skeletal sagittal relationships in
class-II malocclusion. In fact, the group treated during the
pubertal growth spurt presented with all the cephalometric
signs16 that demonstrate the effectiveness of functional
treatment of skeletal class-II disharmony (1) increases in
total mandibular length (co-pg), (2) increases in ramus
height (co-go), (3) opening of the gonial angle (ar-goi-me),
(4) posterior rotation of the condylar line in relation to the
mandibular line (cl-ml), and (5) backward displacement of
the condylar head in relation to the reference system (co-
OLp).
Although not statistically significant, dentoskeletal mod-
ifications during active treatment with the Bionator appli-
ance (T1–T2) deserve to be discussed to compare the short-
term results of the present study with those reported by
other investigators. The craniofacial changes, as evaluated
in the T1–T2 interval in the total treated sample, examined
in this study (23 subjects) approximate those found by Li-
vieratos and Johnston27 in their investigation of short-term
effects of Bionator therapy as the first phase of compre-
hensive class-II correction.
When annualized, increases in mandibular length in both
total treated and untreated samples in this study are similar
to those reported in the randomized clinical trial by Tulloch
et al.28 Illing et al8 reported a two mm/y supplementary
elongation of the mandible in treated subjects with respect
to untreated controls, whereas Bolmgren and Moshiri6
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found an increase of about 2.5 mm/y for the same mea-
surement when compared with normative controls. The re-
sults of the present study confirm the possibility of pro-
ducing about 2.5-mm/y additional increments in total man-
dibular length after Bionator therapy provided that treat-
ment is initiated immediately before the pubertal growth
spurt. Earlier treatment induces a clinically irrelevant
change in mandibular growth (about 1 mm/y more than
untreated controls).
A significant dentoalveolar advancement of the lower
dentition in a mesial direction was detected in the late-treat-
ed sample in the short term. However, no significant move-
ment of the dentition persisted in either of the treated
groups in the long term. Earlier,6 capping of the mandibular
incisors was recommended to prevent flaring of these teeth
during therapy. The appliance design used in the present
study did not include any capping of the lower incisors.
In recent times, the analysis of the effectiveness of the
Bionator appliance when compared with the twin-block is
becoming the most popular alternative clinical option for
functional treatment of class-II malocclusion. The most fa-
vorable time period to start treatment with the twin-block
is during or slightly after the peak in mandibular growth.16
The short-term supplementary mandibular increment that
can be obtained with the twin-block at puberty is approxi-
mately 4.7 mm/y. A similar amount of additional mandib-
ular growth when compared with untreated subjects is
found in patients treated with the Bionator appliance at the
pubertal growth spurt. However, in Bionator therapy this
clinical result is achieved in a two-year time interval, which
is twice the duration of the interval for active twin-block
therapy. Regardless of the differences in both the mode of
action and the clinical management of the two functional
appliances, both the Bionator and the twin-block are effec-
tive therapeutic means for class-II treatment associated with
mandibular deficiency. Nevertheless, the twin-block ap-
pears to be more ‘‘efficient’’ in terms of a shorter duration
of treatment time interval (on average 14 months vs 22
months for the Bionator appliance).
Data regarding the long-term outcomes of twin-block
therapy are needed for a definitive appraisal of the stability
of the very favorable short-term dentoskeletal changes.
Posttreatment stability appears to be a feature of Bionator
therapy followed by fixed appliances to refine occlusion,
both in prepubertal and pubertal patients. None of the skel-
etal parameters exhibited any relapse after active therapy in
the present study. This finding is evident particularly in the
LTG, which still showed small favorable changes even dur-
ing the retention period.
CONCLUSIONS
The findings of the present long-term study on Bionator
therapy followed by fixed appliances in class-II patients in-
dicate that this treatment protocol is effective and stable
when it is initiated immediately before the pubertal growth
spurt. Optimal timing to start treatment with the Bionator
is when a concavity is evident at the lower borders of both
the second and the third cervical vertebrae (CVMS II).
In the long term, the amount of significant supplementary
elongation of the mandible in subjects treated with the
Bionator during the pubertal growth spurt is 5.1 mm more
than that in untreated subjects with class-II malocclusion.
Similar favorable findings can be recorded for the signifi-
cant increments in mandibular ramus height and for a sig-
nificantly more backward direction of condylar growth.
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